EmstoPA

Emstopa email format

Verified email-pattern data for Emstopa is currently limited. You can still use the company insights and contact sections below.
EmstoPA is a first in class antibody-based reversal agent to treat bleeding caused by tissue plasminogen activator (tPA - Activase®, Alteplase®). tPA is a “clot buster” used to remove the blood clots that cause stroke, pulmonary embolism, and myocardial infarction. In the developed world, tPA is most frequently used to treat acute ischemic stroke where the rates of subsequent intracranial hemorrhage (ICH) are 5-7% . EmstoPA belongs to a class of drugs called anti-fibrinolytics, and and the current market for antifibrinolytics is estimated to be $1,100m /year. Currently no specific tPA reversal agents are in development.

Company Details

Founded
-
Address
Discovery Park, Ramsgate Road, Sandwich,ct13 9ff,united Kingdom
Phone
+44 01304 892398
Email
ad****@****opa.com
Industry
Pharmaceutical Manufacturing
Keywords
Sandwich.
HQ
Sandwich
Looking for a particular EmstoPA employee's phone or email?

Emstopa Questions

Explore related pages

Related company profiles:

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant